A drug interaction between fusidic acid and a combination of ritonavir and saquinavir

被引：0
|
作者：
Khaliq, Y
Gallicano, K
Leger, R
Foster, B
Badley, A
机构：
[1] Ottawa Gen Hosp, Clin Invest Unit, Ottawa, ON K1H 8L6, Canada
[2] Ottawa Gen Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada
[3] Univ Ottawa, Ottawa, ON, Canada
[4] Hlth Canada, Specialisees Med Familiale, Ottawa, ON K1A 0L2, Canada
[5] Hlth Canada, Therapeut Prod Programme, Ottawa, ON K1A 0L2, Canada
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2000年 / 50卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：82 / 83
页数：2
相关论文
共 50 条
  • [1] Drug monitoring of Saquinavir and Ritonavir during treatment with Saquinavir or Saquinavir in combination with Ritonavir or Nelfinavir
    Langmann, P
    Zilly, M
    Bienert, A
    Klinker, H
    Richter, E
    AIDS, 1998, 12 : S30 - S30
  • [2] Fusidic acid interactionInteraction with concomitant ritonavir and saquinavir leading to liver disorders: case report
    Reactions Weekly, 2000, 815 (1) : 8 - 8
  • [3] Mechanisms of drug-drug interaction between rifampicin and fusidic acid
    Bel, Florianne
    Bourguignon, Laurent
    Tod, Michel
    Ferry, Tristan
    Goutelle, Sylvain
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (08) : 1862 - 1864
  • [4] Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir
    Kravcik, S
    Gallicano, K
    Roth, V
    Cassol, S
    Hawley-Foss, N
    Badley, A
    Cameron, DW
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (05): : 371 - 375
  • [5] Ritonavir and saquinavir in combination cause hyperlipidaemia
    Reactions Weekly, 1998, 732 (1) : 5 - 5
  • [6] Drug-Drug Interaction Study of Ketoconazole and Ritonavir-Boosted Saquinavir
    Kaeser, Benoite
    Zandt, Hagen
    Bour, Fabrice
    Zwanziger, Elke
    Schmitt, Christophe
    Zhang, Xiaoping
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) : 609 - 614
  • [7] Pharmacokinetics of ritonavir-saquinavir combination therapy
    Cameron, DW
    Hsu, A
    Granneman, GR
    Sun, E
    McMahon, D
    Farthing, C
    Poretz, D
    Markowtiz, M
    Cohen, C
    Follansbee, S
    Mellors, J
    Ho, D
    Xu, Y
    Rode, R
    Salgo, M
    Leonard, J
    AIDS, 1996, 10 : SS56 - SS56
  • [8] Saquinavir drug exposure is not impaired by the boosted double protease inhibitor combination of lopinavir/ritonavir
    Stephan, C
    von Hentig, N
    Kourbeti, I
    Dauer, B
    Mösch, M
    Lutz, T
    Klauke, S
    Harder, S
    Kurowski, M
    Staszewski, S
    AIDS, 2004, 18 (03) : 503 - 508
  • [9] Pharmacokinetic Interaction Study of Ritonavir-Boosted Saquinavir in Combination with Rifabutin in Healthy Subjects
    Zhang, Xiaoping
    Fettner, Scott
    Zwanziger, Elke
    Rowell, Lucy
    Salgo, Miklos
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (02) : 680 - 687
  • [10] Rifampicin interaction with ritonavir-boosted saquinavir
    Reactions Weekly, 2005, 1039 (1) : 4 - 4
12345